Regencell Bioscience Holdings (Regencell Bioscience Holdings) Total Stockholders Equity

: $12.03 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

Regencell Bioscience Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $12.03 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Regencell Bioscience Holdings's Book Value per Share for the quarter that ended in Jun. 2023 was $0.92. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Regencell Bioscience Holdings's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.04.

Regencell Bioscience Holdings Total Stockholders Equity Historical Data

The historical data trend for Regencell Bioscience Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

-1.84

-2.65

-4.00

17.07

12.03

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Stockholders Equity					-4.00	19.70	17.07	14.66	12.03

Regencell Bioscience Holdings (NAS:RGC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Regencell Bioscience Holdings's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(12.03	-	0)	/	13.0129
	=	0.92

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Regencell Bioscience Holdings's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.438	+	0.025)	/	12.03
	=	0.04

Regencell Bioscience Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.